It was reported that AMPAR activation increases high grade glioma proliferation and migration through the Ca2+-dependent activation of Akt/PKB signaling pathway; these effects were inhibited by the use of NBQX, a selective AMPAR inhibitor [195]. Here, AKT1 is linked to central nervous system cancer.